Abstract
Introduction
Cholera is an acute and severe diarrhoeal disease that if left untreated can cause serious 25 dehydration and death within hours 1 . The disease is a major threat, especially in countries 26 lacking proper sanitation, in war zones and after natural disasters. The current outbreak in 27
Yemen (2016) (2017) (2018) ) is the worst in recent history with more than one million reported cases and 28 more than 2,200 deaths 2, 3 . 29
Cholera is easily transmitted between humans through the fecal-oral route, e.g. by consuming 30 food or water contaminated with the bacterium Vibrio cholerae. The bacteria colonize the small 31 intestine and secrete the cholera toxin (CT) 4 . CT belongs to the protein family of AB 5 toxins that 32 consist of one catalytically active A-subunit and a homopentamer of non-toxic B-subunits 4, 5 . The 33 CT B-pentamer (CTB) facilitates binding to epithelial cells in the small intestine and subsequent 34 cellular uptake of the holotoxin 4, 6 . In the cytosol, the A-subunit hijacks the cells' own signalling 35 pathways, causing the secretion of chloride ions into the intestinal lumen and, due to the osmotic 36 gradient, ultimately the severe watery diarrhoea typical of cholera 7, 8 . 37
Key aspects of cholera intoxication are still poorly understood, starting with the interplay 38 between the toxins and their cellular receptors, and the cellular uptake mechanism. For decades, 39 the GM1 ganglioside has been considered to be the only cellular receptor for the CT 9,10 . The 40 binding of CT to the branched GM1 pentasaccharide is one of the strongest protein-carbohydrate 41 interactions known (K d =43 nM) 11 and is mainly due to the two terminal sugar residues galactose 42 and sialic acid, which bind the toxin with a "two-fingered grip" 12 . A large body of research 43 points towards this high affinity interaction being the main entry pathway for the CT 10,13-17 . For 44 example, the incorporation of exogenously added GM1 in human intestinal mucosal cells or 45 rabbit small bowel segments lead to a concentration-dependent increase in the number of toxin 46 receptors and in the sensitivity to the diarrheogenic action of CT 10, 13 . CT binds GM1 at the 47 bottom surface of the B-pentamer, which serves as a landing platform on the cell membrane 12 . 48
More recently, CT was found to bind histo-blood group antigens (BGAs) at a secondary binding 49 site on the lateral side of the B-pentamer, which had originally been discovered for chimeras of 50 CTB and the homologous Escherichia coli heat-labile enterotoxin (LTB) 18 . Cholera toxin 51 naturally occurs in two variants -classical CT (cCT) and El Tor CT (ET CT), which are 52 produced by the corresponding V. cholerae biotypes 4 . However, since 2001 a new vibrio strain 53 has been observed with characteristics of the El Tor biotype that produces CT with the classical 54 amino acid sequence 19 . The two variants only differ in residues 18 and 47 in the secondary CT 55 binding site (cCT: H18, T47, ET CT: Y18, I47) 4,20 , which is why they have been in the focus of 56 cholera blood group binding studies [21] [22] [23] [24] . Moreover, there is increasing evidence that GM1 is not 57 the only CT receptor and may not even be its main receptor 18, [25] [26] [27] [28] [29] [30] [31] . 58
Current research shows that fucosylated structures have an important role in cholera 59 intoxication 29, 30 . CT binds fucosylated human BGAs merely with millimolar affinity [21] [22] [23] [24] , but 60 nevertheless causes blood-group-dependent cellular intoxication 32 . Patients with blood group O 61 are also more likely to get severe cholera symptoms [33] [34] [35] [36] . BGAs are present in the intestine in 62 high concentrations, especially compared to GM1 37 . Most recently, Le x , a BGA precursor 63 expressed on human granulocytes and intestinal cells, has been shown to specifically bind to 64 CTB and was proposed to function as a cellular receptor 30 . Cholera intoxication in mice can be 65 independent of GM1 30 , and fucose-based inhibitors, especially a fucose-containing polymer, are 66 potent inhibitors of CT binding to intestinal cells 31 . It is, however, under debate if and how Le x 67 and related structures bind to the GM1 binding site, the BGA binding site or both 30 . Likewise, it 68 is unknown where and how L-fucose binds to the CT. 69
Here we investigated the binding of CTB to the Le x trisaccharide, L-fucose and the fucosyl-GM1 70 oligosaccharide (os) (Figure 1) 
Results

81
Crystal structures
82
CTB in complex with Le X 83
To study the interaction of CT with Le x , we crystallized purified classical CTB (cCTB) in 84 complex with Le x triaose. Crystals were obtained in two different crystallization conditions. 85
They belonged to space group P2 1 2 1 2 1 and contained two CTB pentamers in the asymmetric unit. 86
Therefore, we can observe 20 crystallographically distinct primary binding and secondary 87 binding sites. The protein structures show the typical "doughnut-shaped" CTB structure of five 88 symmetrically arranged B subunits, each consisting of two three-stranded antiparallel β-beta-89 sheets with α-helices on both sides 12 . The structures were determined to 2.0 Å and 1.5 Å 90 resolution, respectively. In both crystal forms, Le x is only observed in the secondary binding 91 sites of the CT. The binding mode and interactions of Le x described here are based on the 1.5 Å 92 resolution structure, which was refined to a high quality model (Figure 2 a, Table 1 ; R free = 93 22.4%). Generally, the structure is well defined except for the flexible loop comprising residues 94 50-61 and the C-terminal asparagine residue, which exhibits some disorder. TALON-purified cCTB was co-crystallized with L-fucose in a molar ratio of 1:500 (B-subunit to 123 ligand). The crystals belong to space group C2 and contained two CTB pentamers in the 124 asymmetric unit. The structure was refined to 1.95 Å and an R free value of 22.7% (Table 1) . The 125 electron density of the loop regions and the C-terminal Asn103 were more disordered compared 126 to the cCTB-Le x structure, however, overall the structure is well defined. Electron density for β-127 L-fucose is observed in nine of ten secondary binding sites (Figure 3 a,b, Supplementary Table  128 S2). We did not observe electron density corresponding to L-fucose in the GM1 binding site, 129
confirming that fucose only binds to the secondary binding site. Additionally, L-fucose was 130 found sandwiched between two B-pentamers and covalently attached to some of the N-terminal 131 residues. The latter is likely due to non-enzymatic glycosylation 39 . These interactions are 132 unlikely to be biologically relevant and probably caused by the high molar excess of L-fucose 133 added during crystallization. 134
CTB in complex with fucosyl-GM1os 135
Our data strongly suggest that the toxin secondary binding site is the sole binding site for Le x and 136 similar sugars. There is, however, one fucosylated oligosaccharide that would be expected to 137 bind to the primary binding site, namely fucosyl-GM1os. Fucosyl-GM1 binds CT almost as 138 strongly as GM1 40 . We crystallized TALON-purified cCTB with fucosyl-GM1os in a 1:10 molar 139 ratio (B-subunit to ligand), yielding crystals that diffracted to 1.6 Å resolution. The structure was 140 refined to an R free value of 21.4%. Inspection of the electron density revealed that fucosyl-141
GM1os indeed binds to the primary binding site, similarly to GM1os, with the additional fucose 142 residue facing outwards toward the solvent (Figure 3 c) . The electron density for the fucose 143 residue is less well defined compared to the other sugar residues (Figure 3 d Figure S1 ). This result was expected, since there is no major structural 178 difference between free CTB and the B-pentamer in the holotoxin 12,41 . In our crystal structures, 179 Le x and related sugars pre-dominantly bind with the α-anomer of the reducing end GlcNAc, 180 whereas relevant glycoconjugates on the cell surface are β-glycosidically linked to proteins or 181 lipids. Le x tetraose, with a fixed β-anomer, and Le x triaose bound equally well to cCT (K d =8.1 ± 182 3.2 mM for triaose, 7.7 ± 0.5 mM for tetraose), suggesting that the triaose core is mainly 183 responsible for binding and that the linkage does not significantly affect binding affinities. 184
Next, we determined binding affinities for all toxin variants using Le x tetraose (Figure 4, Table  185 2). The primary binding site variant W88K was found to bind Le x tetraose with an affinity 186 comparable to wild-type CT (K d =8.6 ± 0.1 mM for W88K, 7.7 ± 0.5 mM for cCT), whereas 187 H18A, which features a mutation in the secondary binding site, exhibited significantly reduced 188 binding to Le x tetraose (K d >50 mM for H18A, 7.7 ± 0.5 mM for cCT), in agreement with our 189 structural data. This reduced binding affinity is not due to disruption of the primary binding site, 190 receptors in the cell-based assays could allow CT uptake, due to the high affinity of GM1 to 231 CTB, which could explain the findings in the recent study 30 . However, even though Le x and 232 related fucosylated glycans and glycoconjugates do not bind to the primary CT receptor site, 233 clearly additional fucose residues allow for additional attachment points that could interfere with 234 toxin uptake, explaining the strong potency of a fucose-based polymer as CTB inhibitor 31 . 235 for the proposed key hydrophobic residues interacting with C6 in Phe48, possibly together with 256 Ala46 (Figure 2 d) . 257 cCTB binds L-fucose with its free anomeric hydroxyl group in the β-configuration (Figure 3 b) , 258 thus free fucose is not limited to bind in the α-configuration. However, locking the fucose in the 259 β-configuration by the addition of a methyl group would cause steric clashes with residues Thr47 260 and Gly45, explaining why α-linked fucose bound stronger to CTB than β-linked fucose 31 . 261
Comparison
According to Wands et al., OH2 does not contribute significantly as a hydrogen bond acceptor 31 , 262 whereas we observe a hydrogen bond to Gln3# from the adjacent B-subunit (Figure 2 d) . In conclusion, the structural data presented here are a very good match to the reported structure-274 activity relationship data, pointing to the same binding site identified in both studies, moreover lack competition by soluble and mucin-bound CT receptors, leading to more efficient 346 CT uptake and more severe cholera symptoms. 347
Conclusions and perspective 348
The importance of fucosylated sugars for cholera intoxication has recently been in the 349 
Materials and Methods
365
Mutagenesis
366
Vector pARCT5 contains an arabinose-inducible CT operon, with signal sequences derived from 367 the LT-IIb B gene 70 . Site-directed mutagenesis was performed using the manufacturer's protocol 368 (Q5® Site-Directed Mutagenesis Kit, NEB) and DNA oligos (Eurofins Genomics) shown in 369 Table 3 . Successful mutagenesis was verified by Sanger sequencing using primers Seq 1-3 370 (Eurofins Genomics, GATC). 371 
Expression of classical CTB
374
Protein expression was performed essentially as described previously 24 . Briefly, the gene for 375 cCTB (Uniprot: Q57193) was heterologously expressed in E. coli BL21 (DE3) using a cCTB-376 pET21b+ construct. For protein production, cells were grown at 37°C in LB medium containing 377 ampicillin until OD 600 nm of 0.5 was reached. The temperature was reduced to 25°C and 378 isopropyl-β-D-thiogalactopyranoside (IPTG) was added to a final concentration of 0.5 mM to 379 start cCTB production. Cells were harvested after 14-18 h by centrifugation (6900 ×g, 20 min, 380 4°C) and the pellet was re-suspended in ice-cold sucrose buffer (20 mM Tris/HCl, 25% (w/v) 381 sucrose, 5 mM EDTA at pH 8.0). After 15 min on ice, the solution was centrifuged (8000 ×g, 20 382 min, 4°C) and the pellet was re-suspended in periplasmic lysis buffer (5 mM MgCl 2 , 150 μg/mL 383 lysozyme, DNase). The solution was kept cold for 30 min, centrifuged (8000 ×g, 20 min, 4°C) 384 and dialyzed for several hours against PBS in a Snakeskin tube (Thermo Scientific, 3500 385 MWCO). 386
Expression of CTB and CT holotoxins for Talon chromatography
387
The gene for cCTB (Uniprot: Q57193) was heterologously expressed in E. coli BL21 (DE3) 388 using a cCTB-pET21b+ construct. For protein production, cells were grown at 37°C in LB 389 medium containing ampicillin until OD 600 nm of 0.5 was reached. The temperature was reduced to 390 25°C and IPTG was added to a final concentration of 0.5 mM to start cCTB production. 391
The genes for CT and CT variants (W88K, H18A, H18AH94A) were heterologously expressed in 392 OverExpress™ C43 (DE3) cells (Sigma) using pARCT5 or pARCT5 derivatives. For protein 393 production, cells were grown at 37°C in TB medium containing chloramphenicol until OD 600 nm 394 of 2.0 was reached. L-arabinose was added to a final concentration of 0.2% (w/v) to start 395 holotoxin production. 396
Cells were harvested after 14-18 h (CTB) or 3 h (holotoxin) by centrifugation (6900 ×g, 20 min, 397 4°C) and the pellet was re-suspended in 1/60 th volume of Talon A buffer (50 mM sodium 398 phosphate, 300 mM NaCl, pH 8) with 1 mg of polymyxin B (Sigma Aldrich) per mL, 399 cOmplete™ Protease Inhibitor (Roche) and benzonase (EMD Millipore) and shaken at 37°C for 400 15 min. Insoluble debris and cells were removed from the periplasmic extracts by centrifugation 401 (8000 ×g, 20 min, 4°C). The filtered supernatant was directly applied to the Talon affinity 402
column. 403
Purification of cCTB using D-galactose affinity chromatography 404 The protein solution was loaded onto a D-galactose-sepharose affinity column (Thermo 405 Scientific) and eluted using 300 mM galactose in PBS. Fractions containing pure cCTB were 406 pooled and concentrated using Vivaspin 20 mL concentrator tubes (5000 MWCO, PES 407 membrane, Sartorius). The protein was subjected to size-exclusion chromatography using PBS 408 and a Superdex 75 column mounted on an ÄKTA purifier (GE Healthcare). Fractions with toxin 409 were pooled, dialyzed o.n. against Tris buffer (20 mM Tris/HCl, 200 mM NaCl, pH 7.5), 410 concentrated to 3-9 mg/mL, snap-frozen in liquid nitrogen and stored at -80°C. 411
Purification of CTB and CT holotoxins using TALON affinity To improve the density for the terminal fucose residue, GM1os was included prior to fucosyl-480
GM1os. For the cCTB complex with fucose, additional elongated electron density was found in 481 two of the primary binding sites, however, the origin of the density could not be identified, even 482 with Polder 84 maps calculated with the Phenix software suite 78 (the density was clearly not 483 compatible with a sugar ring). PDB_REDO 85 was used to evaluate the models before final 484 refinement steps. Occupancies were refined by evaluating the difference Fourier maps and by 485 comparing the B-factors of the ligands with interacting protein atoms. The final models were 486 analysed using the Analyse geometry task of the CCP4 software suite 75, 76 . The percentages of 487 amino acid residues occupying the favoured, allowed and outlier regions in the Ramachandran 488 plot are 97.5/2.5/0.0% for cCTB-Le x , 97.4/2.4/0.2% for cCTB-L-fucose, and 97.7/2.3/0.0% for 489 cCTB-fucosyl-GM1os, respectively. Figures were generated using PyMol (Schrödinger LLC), α-490 helices and β-strands were assigned using STRIDE 86 . 491
Surface plasmon resonance spectroscopy 492 SPR analyses were performed using Series S CM5 sensor chips and a Biacore T100 biosensor 493 system (Biacore Life Sciences, GE Healthcare, Uppsala, Sweden). Due to the high cost of the 494 oligosaccharides combined with the relatively low affinity typical for carbohydrate-protein 495
interactions, experiments were performed in duplicates or triplicates. Proteins were immobilized 496 on the chip as described previously 24 . Le x tetraose (GLY050, Elicityl) and triaose were dissolved 497 in running buffer (10 mM HEPES/NaOH, 140 mM NaCl, 3 mM EDTA, 0.005 % P20, pH 7.4) 498 and injected in concentrations from 78.125 μM up to 40 mM for 45 s. Dissociation was 499 monitored for additional 15 s. The regeneration was not needed for Le x tetraose, whereas for Le x 500 triaose a short pulse (6 s) of 3 mM NaOH was injected to completely remove it from the surface. 501
Binding of 3.125-200 nM GM1os (GM1a, GLY096, Elicityl) was monitored for 240 s, with 502 additional 420 s for dissociation. The regeneration of the chip was the same as for Le x triaose. All 503 binding steps were performed at 30 μL/min and 25°C. The data were evaluated using Biacore 504 T100 Evaluation software. For GM1os, data were fitted to the mesh, contoured at 3.0σ, generated before placing the ligand) and Trp88 shown in stick 838 representation. Carbohydrate residues are labelled in italics. The terminal fucose and glucose 839 residues show weaker electron density compared to the four core residues of fucosyl-GM1os. 840 841
